Disruptions in this balance, such as through mutations in INTS6 or INTS11, lead to aberrant transcriptional elongation, resistance to CDK9 inhibition, and amplified oncogenic transcriptional responses, linking the INTS complex to both transcriptional regulation and tumor susceptibility (33, 38). This evidence concerns the gene INTS6 and neoplasm.